Inactive Instrument

News CRUCELL

Equities

NL0000358562

End-of-day quote Euronext Amsterdam Other stock markets
- ^EUR	-

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Crucell N.V. : JUDGMENT ISSUED IN CRUCELL N.V. BUY-OUT PROCEEDINGS	12-02-28	PU
CRUCELL : JUDGMENT ISSUED IN CRUCELL N.V. BUY-OUT PROCEEDINGS	12-02-28	GL
CRUCELL : Discovers Important New Antibody Against Influenza A	11-07-07	GL
CRUCELL : Intends to Delist Ordinary Shares on NYSE Euronext	11-03-15	GL
CRUCELL : Johnson & Johnson Acquires 98.89% of Issued Crucell Shares as of the End of the Subsequent Offering Period and Crucell Intends to Delist Crucell Ordinary Shares and ADSs	11-03-08	GL
CRUCELL : Johnson & Johnson Completes Tender Offer for Crucell and Declares Offer Unconditional	11-02-22	GL
CRUCELL : Minimum Acceptance Condition Satisfied	11-02-17	GL
CRUCELL : Shareholders Adopt Offer Governance Resolutions and Johnson & Johnson Makes Announcement on U.S. Regulatory Matters	11-02-08	GL
CRUCELL : Reports Fourth Quarter and Full Year 2010 Results	11-02-07	GL
CRUCELL : Johnson & Johnson Launches Recommended Public Offer to Acquire Crucell	10-12-08	GL
CRUCELL : Johnson & Johnson and Crucell Progress Update: Expect to Commence Public Offer Prior to 10 December 2010	10-11-30	GL
CRUCELL : Reports Third Quarter 2010 Results	10-11-09	GL
CRUCELL : Johnson & Johnson and Crucell Provide Progress Update on Preparations for Public Offer	10-10-29	GL
CRUCELL : Notice of Extraordinary General Meeting of Shareholders	10-10-29	GL
CRUCELL : Puts Temporary Hold on Shipments of Quinvaxem and Hepavax-Gene	10-10-28	GL
CRUCELL : to Convene Initial Informational Extraordinary General Meeting of Shareholders to Discuss Johnson & Johnson Offer	10-10-14	GL
CRUCELL : Johnson & Johnson and Crucell Reach Agreement on Intended Public Offer of ?24.75 per Ordinary Share of Crucell	10-10-06	GL
CRUCELL : Aeras and Crucell Announce Phase II Clinical Trial Start in Kenya	10-09-22	GL
CRUCELL : Johnson & Johnson and Crucell in advanced negotiations for an all cash public offer of EUR24.75 per ordinary share of Crucell	10-09-17	GL
CRUCELL : Reports Record Revenues in Second Quarter 2010	10-08-17	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Like the pros, access all the transcripts and spot the best opportunities before anyone else.

Unlock them now!

fermer